A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Public ClinicalTrials.gov record NCT06919965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Investigator's Choice of Intravesical Chemotherapy in Participants With High-risk Non-muscle-invasive Bladder Cancer With Susceptible FGFR Alterations Who Had Received Intravesical Bacillus Calmette-Guérin (BCG)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or symptoms of the cancer returning, or progressing) between Bacillus Calmette-Guérin (BCG) treated participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of high-risk non-muscle-invasive bladder cancer (HR-NMIBC).
Study identification
- NCT ID
- NCT06919965
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2025
- Primary completion
- Apr 5, 2028
- Completion
- Mar 15, 2032
- Last update posted
- Aug 27, 2026
2025 – 2032
United States locations
- U.S. sites
- 26
- U.S. states
- 19
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Academic Urology and Urogynecology of Arizona | Sun City | Arizona | 85351 | Recruiting |
| UCLA | Los Angeles | California | 90095 | Recruiting |
| Colorado Clinical Research | Lakewood | Colorado | 80228 | Recruiting |
| Advanced Urology Institute | Largo | Florida | 33771 | Recruiting |
| Georgia Urology | Atlanta | Georgia | 30328 | Recruiting |
| Associated Urological Specialists | Chicago Ridge | Illinois | 60415 | Recruiting |
| UroPartners | Glenview | Illinois | 60026 | Recruiting |
| Urology of Indiana | Carmel | Indiana | 46032 | Recruiting |
| Southern Urology LLC | Lafayette | Louisiana | 70508 | Recruiting |
| Greater Boston Urology | Plymouth | Massachusetts | 02360 | Recruiting |
| Comprehensive Urology | Royal Oak | Michigan | 48073 | Recruiting |
| UroHealth Partners | Omaha | Nebraska | 68114 | Completed |
| New Jersey Urology LLC | Voorhees Township | New Jersey | 08043 | Recruiting |
| Associated Medical Professionals | Syracuse | New York | 13210 | Recruiting |
| Dayton Physicians Network Urology | Centerville | Ohio | 45459 | Recruiting |
| The Urology Group | Cincinnati | Ohio | 45212 | Recruiting |
| Helios Clinical Research, LLC | Middleburg Heights | Ohio | 44130 | Completed |
| Oregon Urology Institute | Springfield | Oregon | 97477 | Recruiting |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | Recruiting |
| Keystone Urology Specialists | Lancaster | Pennsylvania | 17604 | Recruiting |
| University Of Pittsburgh Medical Center UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | Recruiting |
| The Conrad Pearson Clinic | Germantown | Tennessee | 38138 | Recruiting |
| Texas Oncology-Austin | Austin | Texas | 78731 | Recruiting |
| Urology Austin | Austin | Texas | 78745 | Recruiting |
| Urology San Antonio PA dba USA Clinical Trials | San Antonio | Texas | 78229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06919965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06919965 live on ClinicalTrials.gov.